Nuvalent
Why Robinhood?
You can watch Nuvalent and buy or sell other stocks, ETFs, and their options commission-free!About NUVL
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.
NUVL Key Statistics
Stock Snapshot
As of today, Nuvalent(NUVL) shares are valued at $123.96. The company's market cap stands at 9.78B, with a P/E ratio of -20.46.
During the trading day, Nuvalent(NUVL) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Nuvalent(NUVL) stock has reached 0, versus its average volume of 554.44K.
The stock's 52-week range extends from a low of $71.13 to a high of $123.99.
The stock's 52-week range extends from a low of $71.13 to a high of $123.99.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.